$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

$nwbo Overview Financials Valuation SEC Filings Company Website

2015 Q3 Form 10-Q Financial Statement

#000114420415063856 Filed on November 09, 2015

Income Statement

Concept	2015 Q3	2014 Q3
Revenue	$291.0K	$582.0K
YoY Change	-50.0%	45.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.330M	$4.140M
YoY Change	4.59%	35.29%
% of Gross Profit
Research & Development	$9.138M	$22.71M
YoY Change	-59.76%	77.48%
% of Gross Profit
Depreciation & Amortization	$29.00K	$346.0K
YoY Change	-91.62%
% of Gross Profit
Operating Expenses	$9.138M	$22.71M
YoY Change	-59.76%	77.48%
Operating Profit	-$13.21M	-$26.61M
YoY Change	-50.34%	72.15%
Interest Expense	$1.046M	$271.0K
YoY Change	285.98%	310.61%
% of Operating Profit
Other Income/Expense, Net	$35.83M	$5.565M
YoY Change	543.81%	-174.7%
Pretax Income	$22.62M	-$21.04M
YoY Change	-207.51%	-8.16%
Income Tax
% Of Pretax Income
Net Earnings	$22.62M	-$21.04M
YoY Change	-207.47%	-8.15%
Net Earnings / Revenue	7771.48%	-3615.64%
Basic Earnings Per Share	$0.29	-$0.35
Diluted Earnings Per Share	$0.25	-$0.35
COMMON SHARES
Basic Shares Outstanding	78.06M shares	60.60M shares
Diluted Shares Outstanding	89.82M shares	60.60M shares

Balance Sheet

Concept	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.390M	$1.400M
YoY Change	285.0%	-51.05%
Cash & Equivalents	$5.392M	$1.403M
Short-Term Investments
Other Short-Term Assets	$1.700M	$170.0K
YoY Change	900.0%	-96.34%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$7.090M	$1.570M
YoY Change	351.59%	-79.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$43.97M	$23.91M
YoY Change	83.87%	16981.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$590.0K	$55.00K
YoY Change	972.73%
Total Long-Term Assets	$44.55M	$27.82M
YoY Change	60.11%	20510.37%
TOTAL ASSETS
Total Short-Term Assets	$7.090M	$1.570M
Total Long-Term Assets	$44.55M	$27.82M
Total Assets	$51.64M	$29.39M
YoY Change	75.71%	284.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$22.79M	$11.50M
YoY Change	98.17%	5.16%
Accrued Expenses	$1.070M	$790.0K
YoY Change	35.44%	-32.48%
Deferred Revenue
YoY Change
Short-Term Debt	$930.0K	$930.0K
YoY Change	0.0%	0.0%
Long-Term Debt Due	$240.0K	$240.0K
YoY Change	0.0%	-64.18%
Total Short-Term Liabilities	$87.25M	$43.30M
YoY Change	101.5%	151.45%
LONG-TERM LIABILITIES
Long-Term Debt	$21.60M	$15.72M
YoY Change	37.4%
Other Long-Term Liabilities	$140.0K	$1.600M
YoY Change	-91.25%	-66.1%
Total Long-Term Liabilities	$21.74M	$17.32M
YoY Change	25.54%	266.73%
TOTAL LIABILITIES
Total Short-Term Liabilities	$87.25M	$43.30M
Total Long-Term Liabilities	$21.74M	$17.32M
Total Liabilities	$109.0M	$60.61M
YoY Change	79.83%	176.25%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock		$446.8M
YoY Change		30.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$57.36M	-$31.22M
YoY Change
Total Liabilities & Shareholders Equity	$51.64M	$29.39M
YoY Change	75.68%	284.99%

Cashflow Statement

Concept	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	$22.62M	-$21.04M
YoY Change	-207.47%	-8.15%
Depreciation, Depletion And Amortization	$29.00K	$346.0K
YoY Change	-91.62%
Cash From Operating Activities	$11.80M	-$8.480M
YoY Change	-239.15%	7.07%
INVESTING ACTIVITIES
Capital Expenditures	-$1.990M	-$22.33M
YoY Change	-91.09%	44560.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$780.0K
YoY Change	-100.0%	-117.33%
Cash From Investing Activities	-$1.990M	-$21.55M
YoY Change	-90.77%	373.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	870.0K	22.57M
YoY Change	-96.15%	69.19%
NET CHANGE
Cash From Operating Activities	$11.80M	-8.480M
Cash From Investing Activities	-1.990M	-21.55M
Cash From Financing Activities	870.0K	22.57M
Net Change In Cash	$11.80M	-7.460M
YoY Change	-258.18%	-957.47%
FREE CASH FLOW
Cash From Operating Activities	$11.80M	-$8.480M
Capital Expenditures	-$1.990M	-$22.33M
Free Cash Flow	$13.79M	$13.85M
YoY Change	-0.43%	-275.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-190000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	72000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17467000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	76301000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	461000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-92949000	USD
CY2014Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	USD
CY2015Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	384000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	582000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	876000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	582000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	876000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	64242000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58307000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12059000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	75774000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-75719000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-74898000	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	18506000	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1702000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-12362000	USD
	us-gaap	Interest Expense InterestExpense	426000	USD
	us-gaap	Interest Expense InterestExpense	3475000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-92949000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1013000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	352000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	50000	USD
	nwbo	Accrued Interest Converted To Common Stock AccruedInterestConvertedToCommonStock	76000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	42000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-90663000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-143000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	22154000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21043000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-90520000	USD
	nwbo	Stock Issued During Period Value Issued For Non Cash Consideration StockIssuedDuringPeriodValueIssuedForNonCashConsideration	521000	USD
	nwbo	Stock Issued During Period Value Redeemable Securities Settlement StockIssuedDuringPeriodValueRedeemableSecuritiesSettlement	299000	USD
	nwbo	Stock Issued During Period Value Conversion Of Accrued Interest StockIssuedDuringPeriodValueConversionOfAccruedInterest	387000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6500000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	264000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40000000	USD
	nwbo	Stock Issued During Period Value Proceeds From Warrants Exercises StockIssuedDuringPeriodValueProceedsFromWarrantsExercises	7431000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	3389000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	563000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	3654000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	7083000	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	15507000	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	1496000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35980000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-56481000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22332000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4010000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24957000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4010000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	25000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	nwbo	Accrued Interest Converted To Common Stock AccruedInterestConvertedToCommonStock	0	USD
	nwbo	Stock And Warrants Issued To Related Party Expenses StockAndWarrantsIssuedToRelatedPartyExpenses	18656000	USD
	nwbo	Stock And Warrants Issued To Related Party Expenses StockAndWarrantsIssuedToRelatedPartyExpenses	9400000	USD
	nwbo	Stock And Warrants Issued For Services And Other Expenses StockAndWarrantsIssuedForServicesAndOtherExpenses	1819000	USD
	nwbo	Stock And Warrants Issued For Services And Other Expenses StockAndWarrantsIssuedForServicesAndOtherExpenses	3389000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	20000	USD
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	0	USD
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	4997000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	138000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18499000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1403000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	0	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	287000	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4817000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	7431000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	6684000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	40000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	nwbo	Proceeds From Issuance Of Common Stock Over Allotment Rights ProceedsFromIssuanceOfCommonStockOverAllotmentRights	0	USD
	nwbo	Proceeds From Issuance Of Common Stock Over Allotment Rights ProceedsFromIssuanceOfCommonStockOverAllotmentRights	15000000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1105000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	52577000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	43841000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-84000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7998000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-17096000	USD
	nwbo	Share Based Compensation Aggregate Non Cash Charges For Non Cash Interest Associated With Accretion Of Our Convertible Notes Discount Net ShareBasedCompensationAggregateNonCashChargesForNonCashInterestAssociatedWithAccretionOfOurConvertibleNotesDiscountNet	26200000	USD
CY2015Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	5400000	USD
CY2015Q3	nwbo	Current Assets Less Payables CurrentAssetsLessPayables	80200000	USD
CY2015Q3	nwbo	Convertible Notes Payable Related Parties ConvertibleNotesPayableRelatedParties	7300000	USD
CY2015Q3	nwbo	Working Capital Deficit WorkingCapitalDeficit	90700000	USD
CY2015Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	56000000	USD
CY2015Q3	nwbo	Noncash Derivative Liability NoncashDerivativeLiability	80200000	USD
CY2015Q3	us-gaap	Accrued Environmental Loss Contingencies Noncurrent AccruedEnvironmentalLossContingenciesNoncurrent	6200000	USD
	us-gaap	Site Contingency Loss Exposure In Excess Of Accrual High Estimate SiteContingencyLossExposureInExcessOfAccrualHighEstimate	4500000	USD
	us-gaap	Site Contingency Loss Exposure In Excess Of Accrual Low Estimate SiteContingencyLossExposureInExcessOfAccrualLowEstimate	32000000	USD
	us-gaap	Site Contingency Loss Exposure In Excess Of Accrual Best Estimate SiteContingencyLossExposureInExcessOfAccrualBestEstimate	6200000	USD
	nwbo	Cash Payments For Services CashPaymentsForServices	7200000	USD
	nwbo	Cash Payments CashPayments	28400000	USD
CY2014	nwbo	Cash Payments For Services CashPaymentsForServices	5700000	USD
	nwbo	Cash Payments CashPayments	12800000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.25
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
CY2015Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2800000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	204000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	160000	USD
	us-gaap	Depreciation Depreciation	44000	USD
	us-gaap	Depreciation Depreciation	352000	USD
CY2015Q3	us-gaap	Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations	151000	USD
	us-gaap	Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations	502000	USD
CY2015Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	200000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	763000	USD
CY2015Q3	us-gaap	Interest And Debt Expense InterestAndDebtExpense	499000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1859000	USD
CY2015Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	80000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	292000	USD
CY2015Q3	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	68000	USD
	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	302000	USD
CY2015Q3	us-gaap	Notes Payable NotesPayable	1172000	USD
CY2014Q4	us-gaap	Notes Payable NotesPayable	1172000	USD
CY2015Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	888187	shares
CY2015Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3700000	USD
CY2015Q1	nwbo	Fair Value Of Warrants At Issuance Date FairValueOfWarrantsAtIssuanceDate	500000	USD
CY2015Q1	nwbo	Fair Value Of Common Stock Issued For Redemption Of Redeemable Securities FairValueOfCommonStockIssuedForRedemptionOfRedeemableSecurities	300000	USD
CY2015Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	80068	shares
CY2015Q1	nwbo	Stock Issued During Period Shares Cashless Exercise Of Warrants StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants	385000	shares
CY2015Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	7.40
CY2015Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	5405405	shares
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	40000000	USD
CY2015Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	4500000	USD
CY2015Q2	nwbo	Stock Issued During Period Exercise Of Warrants StockIssuedDuringPeriodExerciseOfWarrants	723422	shares
CY2015Q2	nwbo	Stock Issued During Period Shares Extinguishment Of Warrant Liabilities StockIssuedDuringPeriodSharesExtinguishmentOfWarrantLiabilities	9200	shares
CY2015Q2	nwbo	Stock Issued During Period Value Extinguishment Of Warrant Liabilities StockIssuedDuringPeriodValueExtinguishmentOfWarrantLiabilities	60000	USD
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	USD
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	2625000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	16220000	USD
	nwbo	Reclass Of Redeemable Security To Equity ReclassOfRedeemableSecurityToEquity	0	USD
CY2015Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	701033	shares
	nwbo	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	4.66
	nwbo	Weighted Average Exercise Pricewarrants Exercised On Cashless Basis WeightedAverageExercisePricewarrantsExercisedOnCashlessBasis	3.96
	nwbo	Weighted Average Exercise Price Exercised For Cash WeightedAverageExercisePriceExercisedForCash	4.25
	nwbo	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	2382000	shares
	nwbo	Number Of Warrants Warrants Exercised For Cash NumberOfWarrantsWarrantsExercisedForCash	1678000	shares
	nwbo	Number Of Warrants Warrants Exercised On Cashless Basis NumberOfWarrantsWarrantsExercisedOnCashlessBasis	304000	shares
	nwbo	Number Of Warrants Adjustment Related To Prior Issued Warrants NumberOfWarrantsAdjustmentRelatedToPriorIssuedWarrants	280000	shares
	nwbo	Weighted Average Exercise Price Adjustment Related To Prior Issued Warrants WeightedAverageExercisePriceAdjustmentRelatedToPriorIssuedWarrants	4.41
	nwbo	Number Of Warrants Adjusted Due To Price Reset NumberOfWarrantsAdjustedDueToPriceReset	62000	shares
	nwbo	Weighted Average Price Of Warrant Adjustment Due To Price Reset WeightedAveragePriceOfWarrantAdjustmentDueToPriceReset	3.35
	nwbo	Warrants Issued During Period WarrantsIssuedDuringPeriod	14323003	shares
	nwbo	Warrants Issued Weighted Average Exercise Price Per Warrant WarrantsIssuedWeightedAverageExercisePricePerWarrant	3.3
	nwbo	Warrants Issued Weighted Average Remaining Contractual Term WarrantsIssuedWeightedAverageRemainingContractualTerm	P4Y2M12D
CY2015Q3	nwbo	Accrued Expenses Related Party AccruedExpensesRelatedParty	11000	USD
CY2014Q4	nwbo	Accrued Expenses Related Party AccruedExpensesRelatedParty	8000	USD
CY2015Q3	nwbo	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	50000	USD
CY2014Q4	nwbo	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	50000	USD
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78169566	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78169566	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68957469	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68957469	shares
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.64
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.64
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	71000	USD
	nwbo	Reclass Of Redeemable Security To Equity ReclassOfRedeemableSecurityToEquity	8913000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	51000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	1280000	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise	521000	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise	0	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Warrants Exercised For Cash ReclassificationOfWarrantLiabilitiesRelatedToWarrantsExercisedForCash	264000	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Warrants Exercised For Cash ReclassificationOfWarrantLiabilitiesRelatedToWarrantsExercisedForCash	0	USD
	nwbo	Issuance Of Common Stock For Debt Conversion IssuanceOfCommonStockForDebtConversion	6500000	USD
	nwbo	Issuance Of Common Stock For Debt Conversion IssuanceOfCommonStockForDebtConversion	0	USD
	nwbo	Redeemable Security Settlement RedeemableSecuritySettlement	299000	USD
	nwbo	Redeemable Security Settlement RedeemableSecuritySettlement	0	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Use of Estimates</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 34.1pt; MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt">  </font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In preparing financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payment arrangements, valuing environmental liabilities, estimating the fair value of equity instruments recorded as derivative liabilities, and estimating the useful lives of depreciable assets and whether impairment charges may apply.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	44169000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	40159000	USD
CY2015Q3	us-gaap	Depreciation Depreciation	29000	USD
CY2014Q3	us-gaap	Depreciation Depreciation	346000	USD
CY2015Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	188000	USD
CY2014Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	188000	USD
CY2015Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	50000	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	50000	USD
CY2014Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	29385000	shares
CY2015Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	25363000	shares
CY2015Q3	nwbo	Stock Issued During Period Shares Exercise Of Warrant StockIssuedDuringPeriodSharesExerciseOfWarrant	116675	shares
CY2015Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	800000	USD
CY2015Q3	nwbo	Stock Issued During Period Shares Extinguishment Of Warrant Liabilities StockIssuedDuringPeriodSharesExtinguishmentOfWarrantLiabilities	57500	shares
CY2015Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	79000	USD
CY2014Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	22694000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-21043000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-90663000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-92949000	USD
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78062000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60604000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74394000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56838000	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	12373000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1811000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	2425000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	0	shares
	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	0	shares
	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	0	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89821000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60604000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74394000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56838000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28725000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27213000	shares
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	9400000	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	1854000	USD
	us-gaap	Environmental Expense And Liabilities EnvironmentalExpenseAndLiabilities	0	USD
	us-gaap	Environmental Expense And Liabilities EnvironmentalExpenseAndLiabilities	1600000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	143000	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Reclassifications</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">  </font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company reclassified debt issuance costs from other long-term assets to long-term debt, net on the condensed consolidated balance sheets for all periods presented pursuant to early adoption of Accounting Standards Update ("ASU") No. 2015-03 - <i>Simplifying the Presentation of Debt Issuance Costs</i>.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	nwbo	Issuance Of Common Stock For Conversion Of Accrued Interest IssuanceOfCommonStockForConversionOfAccruedInterest	387000	USD
	nwbo	Issuance Of Common Stock For Conversion Of Accrued Interest IssuanceOfCommonStockForConversionOfAccruedInterest	0	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	nwbo	Share Based Compensation Aggregate Non Cash Charges For Non Cash Interest Associated With Accretion Of Our Convertible Notes Discount Net ShareBasedCompensationAggregateNonCashChargesForNonCashInterestAssociatedWithAccretionOfOurConvertibleNotesDiscountNet	92900000	USD
CY2015Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11800000	USD
CY2015Q3	us-gaap	Share Based Compensation ShareBasedCompensation	-6400000	USD
CY2014Q3	us-gaap	Share Based Compensation ShareBasedCompensation	900000	USD
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	85228	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	700000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	184000	USD
CY2015Q3	nwbo	Cash Payments CashPayments	7100000	USD
CY2014Q3	nwbo	Cash Payments CashPayments	1400000	USD

Files In Submission

Name	View Source	Status
0001144204-15-063856-index-headers.html	Edgar Link	pending
0001144204-15-063856-index.html	Edgar Link	pending
0001144204-15-063856.txt	Edgar Link	pending
0001144204-15-063856-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nwbo-20150930.xml	Edgar Link	completed
nwbo-20150930.xsd	Edgar Link	pending
nwbo-20150930_cal.xml	Edgar Link	unprocessable
nwbo-20150930_def.xml	Edgar Link	unprocessable
nwbo-20150930_lab.xml	Edgar Link	unprocessable
nwbo-20150930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v423331_10q.htm	Edgar Link	pending
v423331_ex31-1.htm	Edgar Link	pending
v423331_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2015 Q3 Form 10-Q Financial Statement

#000114420415063856 Filed on November 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2015 Q3 Form 10-Q Financial Statement

#000114420415063856 Filed on November 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo